Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05259696
Title Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) (GLIMMER-01)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Palleon Pharmaceuticals, Inc.
Indications

melanoma

lung non-small cell carcinoma

colorectal cancer

ovarian cancer

pancreatic cancer

Therapies

E-602

E-602 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.